Decreased expression of miRNA-216a was found in NSCLC patients' specimens and by directly targeting eIF4B and ZEB1, miRNA-216a could inhibit NSCLC cell growth and metastasis [17]. The gene discussed is ZEB1; the disease is non-small cell lung carcinoma.